{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:56:49Z","timestamp":1772769409690,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s Disease (PD) is a neurodegenerative disorder characterized by the depletion of dopaminergic neurons in the substantia nigra, leading to hallmark motor symptoms such as bradykinesia, tremor, and rigidity. While the focus of PD has been on motor changes, dermatological changes are also commonly seen and may even precede the neurological symptoms. Individuals with PD may exhibit impaired wound healing, potentially due to dysregulated mechanisms involving epidermal growth factor (EGF) and N-methyl-D-aspartate (NMDA) in keratinocytes. This paper hypothesizes that the potential for impaired wound healing in PD patients is linked to reduced EGFR activity and altered NMDAR subunit expression in keratinocytes, in contrast to the upregulated wound healing seen in conditions like psoriasis, which demonstrates elevated EGFR and changes in NMDAR subunit activity. Furthermore, a potential co-interaction between EGF and NMDA in keratinocytes may further contribute to impaired wound healing. Investigating these signaling mechanisms can improve understanding and management of associated dermatological symptoms. We propose additional studies to quantify differences in rates of wound healing between PD patients and age-matched controls in effort to explore therapeutic targets for enhancing wounding healing in the context of PD.<\/jats:p>","DOI":"10.1186\/s10020-025-01247-w","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T17:01:52Z","timestamp":1747933312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impaired wound healing in Parkinson\u2019s disease: a hypothesis on altered epidermal growth factor (EGF) and N-methyl-D-aspartate (NMDA) signaling in keratinocytes"],"prefix":"10.1186","volume":"31","author":[{"given":"Caroline","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Ghebrehiwet-Kuflom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn Rivkah","family":"Isseroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Dahle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Morhenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"1","key":"1247_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0006-8993(92)91433-f","volume":"31","author":"K Abe","year":"1992","unstructured":"Abe K, Saito H. Epidermal growth factor selectively enhances NMDA receptor-mediated increase of intracellular Ca2\u2009+\u2009concentration in rat hippocampal neurons. Brain Res Jul. 1992;31(1):102\u20138. https:\/\/doi.org\/10.1016\/0006-8993(92)91433-f","journal-title":"Brain Res Jul"},{"key":"1247_CR16","unstructured":"Alavi A, Kirsner RS et al. Wound Healing. In: Kang S, Amagai M, Bruckner AL, eds. Fitzpatrick\u2019s Dermatology, 9e. McGraw-Hill Education; 2019."},{"issue":"6","key":"1247_CR2","first-page":"26","volume":"59","author":"JM Beitz","year":"2013","unstructured":"Beitz JM. Skin and wound issues in patients with Parkinson\u2019s disease: an overview of common disorders. Ostomy Wound Manage Jun. 2013;59(6):26\u201336.","journal-title":"Ostomy Wound Manage Jun"},{"issue":"4","key":"1247_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1586\/eem.12.34","volume":"7","author":"DD Bikle","year":"2012","unstructured":"Bikle DD, Xie Z, Tu CL. Calcium regulation of keratinocyte differentiation. Expert Rev Endocrinol Metab Jul. 2012;7(4):461\u201372. https:\/\/doi.org\/10.1586\/eem.12.34","journal-title":"Expert Rev Endocrinol Metab Jul"},{"key":"1247_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cacc.2008.05.004","volume":"19","author":"H Chaffey","year":"2008","unstructured":"Chaffey H, Chazot PL. NMDA receptor subtypes: structure, function and therapeutics. Curr Anaesth Crit Care. 2008;19:183\u2013201.","journal-title":"Curr Anaesth Crit Care"},{"issue":"4","key":"1247_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.22271","volume":"69","author":"AS Chen-Plotkin","year":"2011","unstructured":"Chen-Plotkin AS, Hu WT, Siderowf A, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol Apr. 2011;69(4):655\u201363. https:\/\/doi.org\/10.1002\/ana.22271","journal-title":"Ann Neurol Apr"},{"issue":"3","key":"1247_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-0625.2006.00529.x","volume":"16","author":"M Denda","year":"2007","unstructured":"Denda M, Nakatani M, Ikeyama K, Tsutsumi M, Denda S. Epidermal keratinocytes as the forefront of the sensory system. Exp Dermatol Mar. 2007;16(3):157\u201361. https:\/\/doi.org\/10.1111\/j.1600-0625.2006.00529.x","journal-title":"Exp Dermatol Mar"},{"issue":"4892","key":"1247_CR28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1126\/science.2916128","volume":"10","author":"JT Elder","year":"1989","unstructured":"Elder JT, Fisher GJ, Lindquist PB, et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Sci Feb. 1989;10(4892):811\u20134. https:\/\/doi.org\/10.1126\/science.2916128","journal-title":"Sci Feb"},{"issue":"12","key":"1247_CR47","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/j.1600-0625.2009.00886.x","volume":"18","author":"M Fischer","year":"2009","unstructured":"Fischer M, Glanz D, Urbatzka M, Brzoska T, Abels C. Keratinocytes: a source of the transmitter L-glutamate in the epidermis. Exp Dermatol Dec. 2009;18(12):1064\u20136. https:\/\/doi.org\/10.1111\/j.1600-0625.2009.00886.x","journal-title":"Exp Dermatol Dec"},{"issue":"4","key":"1247_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ced.12356","volume":"39","author":"I Flisiak","year":"2014","unstructured":"Flisiak I, Szterling-Jaworowska M, Baran A, Rogalska\u2010Taranta M. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales. Clin Exp Dermatol. 2014;39(4):461\u20137. https:\/\/doi.org\/10.1111\/ced.12356","journal-title":"Clin Exp Dermatol"},{"key":"1247_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/DDDT.S51559","volume":"8","author":"J Gan","year":"2014","unstructured":"Gan J, Qi C, Mao LM, Liu Z. Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson\u2019s disease. Drug Des Devel Ther. 2014;8:165\u201373. https:\/\/doi.org\/10.2147\/DDDT.S51559","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"1247_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1046\/j.1524-475x.2000.00192.x","volume":"8","author":"S Gibbs","year":"2000","unstructured":"Gibbs S, Silva Pinto AN, Murli S, Huber M, Hohl D, Ponec M. Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound repair Regen. May-Jun. 2000;8(3):192\u2013203. https:\/\/doi.org\/10.1046\/j.1524-475x.2000.00192.x","journal-title":"May-Jun"},{"issue":"2","key":"1247_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1684\/ejd.2010.0882","volume":"20","author":"E Giroux Leprieur","year":"2010","unstructured":"Giroux Leprieur E, Friard S, Couderc LJ. Improvement of psoriasis in a lung cancer patient treated with erlotinib. Eur J Dermatol Mar-Apr. 2010;20(2):243\u20134. https:\/\/doi.org\/10.1684\/ejd.2010.0882","journal-title":"Eur J Dermatol Mar-Apr"},{"issue":"1","key":"1247_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1113\/jphysiol.2014.273763","volume":"1","author":"NG Glasgow","year":"2015","unstructured":"Glasgow NG, Siegler Retchless B, Johnson JW. Molecular bases of NMDA receptor subtype-dependent properties. J Physiol Jan. 2015;1(1):83\u201395. https:\/\/doi.org\/10.1113\/jphysiol.2014.273763","journal-title":"J Physiol Jan"},{"issue":"6","key":"1247_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/jid.2014.7","volume":"134","author":"F Gorouhi","year":"2014","unstructured":"Gorouhi F, Shah NM, Krishna Raghunathan V, et al. Epidermal growth factor-functionalized polymeric multilayer films: interplay between Spatial location and bioavailability of EGF. J Invest Dermatol Jun. 2014;134(6):1757\u201360. https:\/\/doi.org\/10.1038\/jid.2014.7","journal-title":"J Invest Dermatol Jun"},{"issue":"2","key":"1247_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.167.2.670","volume":"1","author":"AB Gottlieb","year":"1988","unstructured":"Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP. Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med Feb. 1988;1(2):670\u20135. https:\/\/doi.org\/10.1084\/jem.167.2.670","journal-title":"J Exp Med Feb"},{"issue":"1","key":"1247_CR41","doi-asserted-by":"publisher","first-page":"11608","DOI":"10.1038\/s41598-017-11947-x","volume":"14","author":"H Guo","year":"2017","unstructured":"Guo H, Camargo LM, Yeboah F, et al. A NMDA-receptor calcium influx assay sensitive to stimulation by glutamate and glycine\/D-serine. Sci Rep Sep. 2017;14(1):11608. https:\/\/doi.org\/10.1038\/s41598-017-11947-x","journal-title":"Sci Rep Sep"},{"issue":"2","key":"1247_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","volume":"102","author":"PJ Hallett","year":"2004","unstructured":"Hallett PJ, Standaert DG. Rationale for and use of NMDA receptor antagonists in Parkinson\u2019s disease. Pharmacol Ther May. 2004;102(2):155\u201374. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.04.001","journal-title":"Pharmacol Ther May"},{"issue":"4","key":"1247_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-4159.2005.03073.x","volume":"93","author":"Y Iwakura","year":"2005","unstructured":"Iwakura Y, Piao YS, Mizuno M, et al. Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson\u2019s disease and its model: neurotrophic implication in nigrostriatal neurons. J Neurochem May. 2005;93(4):974\u201383. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03073.x","journal-title":"J Neurochem May"},{"issue":"3","key":"1247_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.14336\/AD.2014.0925","volume":"6","author":"QW Jiang","year":"2015","unstructured":"Jiang QW, Wang C, Zhou Y, et al. Plasma epidermal growth factor decreased in the early stage of Parkinson\u2019s disease. Aging Dis Jun. 2015;6(3):168\u201373. https:\/\/doi.org\/10.14336\/AD.2014.0925","journal-title":"Aging Dis Jun"},{"issue":"5","key":"1247_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/acn3.299","volume":"3","author":"NS Lim","year":"2016","unstructured":"Lim NS, Swanson CR, Cherng HR, et al. Plasma EGF and cognitive decline in Parkinson\u2019s disease and Alzheimer\u2019s disease. Ann Clin Transl Neurol May. 2016;3(5):346\u201355. https:\/\/doi.org\/10.1002\/acn3.299","journal-title":"Ann Clin Transl Neurol May"},{"issue":"12","key":"1247_CR19","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1038\/jid.2012.211","volume":"132","author":"W Liu","year":"2012","unstructured":"Liu W, Hsu DK, Chen HY, et al. Galectin-3 regulates intracellular trafficking of EGFR through alix and promotes keratinocyte migration. J Invest Dermatol Dec. 2012;132(12):2828\u201337. https:\/\/doi.org\/10.1038\/jid.2012.211","journal-title":"J Invest Dermatol Dec"},{"key":"1247_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fncel.2015.00245","volume":"9","author":"M Mellone","year":"2015","unstructured":"Mellone M, Stanic J, Hernandez LF, et al. NMDA receptor GluN2A\/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. Front Cell Neurosci. 2015;9:245. https:\/\/doi.org\/10.3389\/fncel.2015.00245","journal-title":"Front Cell Neurosci"},{"key":"1247_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nbd.2018.09.021","volume":"121","author":"M Mellone","year":"2019","unstructured":"Mellone M, Zianni E, Stanic J, et al. NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology. Neurobiol Dis Jan. 2019;121:338\u201349. https:\/\/doi.org\/10.1016\/j.nbd.2018.09.021","journal-title":"Neurobiol Dis Jan"},{"issue":"3","key":"1247_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0922-4106(94)90066-3","volume":"16","author":"VB Morhenn","year":"1994","unstructured":"Morhenn VB, Waleh NS, Mansbridge JN, et al. Evidence for an NMDA receptor subunit in human keratinocytes and rat cardiocytes. Eur J Pharmacol Aug. 1994;16(3):409\u201314. https:\/\/doi.org\/10.1016\/0922-4106(94)90066-3","journal-title":"Eur J Pharmacol Aug"},{"issue":"8","key":"1247_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.0906-6705.2004.00186.x","volume":"13","author":"VB Morhenn","year":"2004","unstructured":"Morhenn VB, Murakami M, O\u2019Grady T, Nordberg J, Gallo RL. Characterization of the expression and function of N-methyl-D-aspartate receptor in keratinocytes. Exp Dermatol Aug. 2004;13(8):505\u201311. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00186.x","journal-title":"Exp Dermatol Aug"},{"issue":"2","key":"1247_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jdermsci.2013.06.001","volume":"72","author":"VB Morhenn","year":"2013","unstructured":"Morhenn VB, Nelson TE, Gruol DL. The rate of wound healing is increased in psoriasis. J Dermatol Sci Nov. 2013a;72(2):87\u201392. https:\/\/doi.org\/10.1016\/j.jdermsci.2013.06.001","journal-title":"J Dermatol Sci Nov"},{"issue":"11","key":"1247_CR48","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/exd.12242","volume":"22","author":"VB Morhenn","year":"2013","unstructured":"Morhenn VB, Nahm WJ, Mansbridge JN. Psoriatic keratinocytes are resistant to tumor necrosis factor Alpha\u2019s induction of mRNA for the NMDA-R2C subunit. Exp Dermatol Nov. 2013b;22(11):750\u20131. https:\/\/doi.org\/10.1111\/exd.12242","journal-title":"Exp Dermatol Nov"},{"issue":"2","key":"1247_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jcp.20010","volume":"200","author":"WK Nahm","year":"2004","unstructured":"Nahm WK, Philpot BD, Adams MM, et al. Significance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol Aug. 2004;200(2):309\u201317. https:\/\/doi.org\/10.1002\/jcp.20010","journal-title":"J Cell Physiol Aug"},{"key":"1247_CR25","doi-asserted-by":"publisher","unstructured":"Nakamura Y, Sotozono C, Kinoshita S. The Epidermal Growth Factor Receptor (EGFR): Role in Corneal Wound Healing and Homeostasis. Experimental Eye Research. 2001\/05\/01\/2001;72(5):511-517. https:\/\/doi.org\/10.1006\/exer.2000.0979","DOI":"10.1006\/exer.2000.0979"},{"issue":"3","key":"1247_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/1523-1747.ep12285389","volume":"86","author":"LB Nanney","year":"1986","unstructured":"Nanney LB, Stoscheck CM, Magid M, King LE Jr. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol Mar. 1986;86(3):260\u20135. https:\/\/doi.org\/10.1111\/1523-1747.ep12285389","journal-title":"J Invest Dermatol Mar"},{"issue":"2","key":"1247_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000342786","volume":"225","author":"TR Overbeck","year":"2012","unstructured":"Overbeck TR, Griesinger F. Two cases of psoriasis responding to erlotinib: time to revisiting Inhibition of epidermal growth factor receptor in psoriasis therapy? Dermatology. 2012;225(2):179\u201382. https:\/\/doi.org\/10.1159\/000342786","journal-title":"Dermatology"},{"issue":"6","key":"1247_CR32","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.jaad.2011.08.009","volume":"66","author":"N Oyama","year":"2012","unstructured":"Oyama N, Kaneko F, Togashi A, Yamamoto T. A case of rapid improvement of severe psoriasis during molecular-targeted therapy using an epidermal growth factor receptor tyrosine kinase inhibitor for metastatic lung adenocarcinoma. J Am Acad Dermatol Jun. 2012;66(6):e251\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2011.08.009","journal-title":"J Am Acad Dermatol Jun"},{"issue":"3","key":"1247_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/RLI.0000000000000929","volume":"1","author":"CC Quattrocchi","year":"2023","unstructured":"Quattrocchi CC, Parillo M, Spani F, et al. Skin thickening of the scalp and high signal intensity of dentate nucleus in multiple sclerosis: association with linear versus macrocyclic Gadolinium-Based contrast agents administration. Invest Radiol Mar. 2023;1(3):223\u201330. https:\/\/doi.org\/10.1097\/RLI.0000000000000929","journal-title":"Invest Radiol Mar"},{"issue":"6","key":"1247_CR21","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1021\/acsbiomaterials.1c00192","volume":"14","author":"V Raghunathan","year":"2021","unstructured":"Raghunathan V, Park SA, Shah NM, et al. Changing the wound: covalent immobilization of the epidermal growth factor. ACS Biomater Sci Eng Jun. 2021;14(6):2649\u201360. https:\/\/doi.org\/10.1021\/acsbiomaterials.1c00192","journal-title":"ACS Biomater Sci Eng Jun"},{"key":"1247_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/CCID.S130319","volume":"10","author":"AH Ravn","year":"2017","unstructured":"Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinson\u2019s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87\u201392. https:\/\/doi.org\/10.2147\/CCID.S130319","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1247_CR24","doi-asserted-by":"publisher","unstructured":"Repertinger SK, Campagnaro E, Fuhrman J, El-Abaseri T, Yuspa SH, Hansen LA. EGFR Enhances Early Healing After Cutaneous Incisional Wounding. Journal of Investigative Dermatology. 2004\/11\/01\/2004;123(5):982-989. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23478.x","DOI":"10.1111\/j.0022-202X.2004.23478.x"},{"key":"1247_CR6","doi-asserted-by":"crossref","unstructured":"Saikia A, Hussain M, Barua AR, Paul S. Chapter 9 - An insight into Parkinson\u2019s disease: researches and its complexities. In: Paul S, Bhatia D, editors. Smart healthcare for disease diagnosis and prevention. Academic; 2020. pp. 59\u201380.","DOI":"10.1016\/B978-0-12-817913-0.00009-2"},{"issue":"3","key":"1247_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jcp.21635","volume":"218","author":"MR Schneider","year":"2009","unstructured":"Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol Mar. 2009;218(3):460\u20136. https:\/\/doi.org\/10.1002\/jcp.21635","journal-title":"J Cell Physiol Mar"},{"issue":"5","key":"1247_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI119641","volume":"1","author":"S Stoll","year":"1997","unstructured":"Stoll S, Garner W, Elder J. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest Sep. 1997;1(5):1271\u201381. https:\/\/doi.org\/10.1172\/JCI119641","journal-title":"J Clin Invest Sep"},{"issue":"12","key":"1247_CR15","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1111\/cas.13826","volume":"109","author":"K Suina","year":"2018","unstructured":"Suina K, Tsuchihashi K, Yamasaki J, et al. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling. Cancer Sci Dec. 2018;109(12):3874\u201382. https:\/\/doi.org\/10.1111\/cas.13826","journal-title":"Cancer Sci Dec"},{"key":"1247_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2015.07.021","volume":"24","author":"Y Tang","year":"2015","unstructured":"Tang Y, Ye M, Du Y, et al. EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neurosci Sep. 2015;24:304:109\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.07.021","journal-title":"Neurosci Sep"},{"issue":"2","key":"1247_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1083\/jcb.151.2.209","volume":"151","author":"S Tokumaru","year":"2000","unstructured":"Tokumaru S, Higashiyama S, Endo T, et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol. 2000;151(2):209\u201320. https:\/\/doi.org\/10.1083\/jcb.151.2.209","journal-title":"J Cell Biol"},{"key":"1247_CR13","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000164","author":"TH Turner","year":"2014","unstructured":"Turner TH, Granholm A-C, Duppstadt-Delambo A, Boger H, Kumaraswamy G, Hinson V. Epidermal growth factor (EGF) is associated with memory and executive functioning in progressed Parkinson\u2019s disease. J Alzheimers Disease Parkinsonism. 2014. https:\/\/doi.org\/10.4172\/2161-0460.1000164","journal-title":"J Alzheimers Disease Parkinsonism"},{"issue":"7","key":"1247_CR3","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1111\/iwj.14154","volume":"20","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang S, Yang X. Prevalence of different types of wound infection in subjects with Parkinson\u2019s disease and total joint arthroplasty: A meta-Analysis. Int Wound J. 2023;20(7):2780\u20137. https:\/\/doi.org\/10.1111\/iwj.14154","journal-title":"Int Wound J"},{"issue":"2","key":"1247_CR50","doi-asserted-by":"publisher","first-page":"H772","DOI":"10.1152\/ajpheart.00606.2020","volume":"1","author":"SG Wei","year":"2021","unstructured":"Wei SG, Yu Y, Felder RB. TNF-alpha-induced sympathetic excitation requires EGFR and ERK1\/2 signaling in cardiovascular regulatory regions of the forebrain. Am J Physiol Heart Circ Physiol. Feb 2021;1(2):H772\u201386. https:\/\/doi.org\/10.1152\/ajpheart.00606.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1247_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2133.2006.07299.x","volume":"155","author":"E Wierzbicka","year":"2006","unstructured":"Wierzbicka E, Tourani JM, Guillet G. Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis? Br J Dermatol Jul. 2006;155(1):213\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07299.x","journal-title":"Br J Dermatol Jul"},{"issue":"1","key":"1247_CR5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1186\/s12877-023-04580-z","volume":"19","author":"Z Xie","year":"2023","unstructured":"Xie Z, Gao Y, Tian L, Jiang Y, Zhang H, Su Y. Pemphigus and pemphigoid are associated with Alzheimer\u2019s disease in older adults: evidence from the US nationwide inpatient sample 2016\u20132018. BMC Geriatr Dec. 2023;19(1):872. https:\/\/doi.org\/10.1186\/s12877-023-04580-z","journal-title":"BMC Geriatr Dec"},{"issue":"6","key":"1247_CR26","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1167\/iovs.10-5670","volume":"17","author":"K Xu","year":"2011","unstructured":"Xu K, Yu FS. Impaired epithelial wound healing and EGFR signaling pathways in the Corneas of diabetic rats. Invest Ophthalmol Vis Sci May. 2011;17(6):3301\u20138. https:\/\/doi.org\/10.1167\/iovs.10-5670","journal-title":"Invest Ophthalmol Vis Sci May"},{"issue":"8","key":"1247_CR49","doi-asserted-by":"publisher","first-page":"G805","DOI":"10.1152\/ajpgi.00522.2011","volume":"15","author":"J Yoo","year":"2012","unstructured":"Yoo J, Rodriguez Perez CE, Nie W, Edwards RA, Sinnett-Smith J, Rozengurt E. TNF-alpha induces upregulation of EGFR expression and signaling in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol Apr. 2012;15(8):G805\u201314. https:\/\/doi.org\/10.1152\/ajpgi.00522.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol Apr"},{"key":"1247_CR42","doi-asserted-by":"publisher","unstructured":"Zhang Z, Zhang S, Fu P, et al. Roles of Glutamate Receptors in Parkinson\u2019s Disease. Int J Mol Sci Sep. 2019;6(18). https:\/\/doi.org\/10.3390\/ijms20184391","DOI":"10.3390\/ijms20184391"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01247-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01247-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T17:01:53Z","timestamp":1747933313000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01247-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1247"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01247-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}